Côte St. Luc City speaks out on Chanukah massacre in Australia ...

Libtayo's approval for high-risk cutaneous squamous cell carcinoma offers a new immunotherapy option, targeting PD-1 ...

Atopic dermatitis’ (AD) deeper complexities were exposed in 2025. Once seen mainly as a visible skin condition, AD is now widely recognized as a long-lasting inflammatory disease that affects sleep, ...

Medical and health news service that features the most comprehensive coverage in the fields of neuroscience, cardiology, cancer, HIV/AIDS, psychology, psychiatry, dentistry, genetics, diseases and ...

Post-hoc analyses of the phase III ARCADIA and OLYMPIA clinical trial programs, published in the Journal of the European Academy of Dermatology and Venereology, highlight nemolizumab’s fast onset of ...

There is little awareness, particularly among clinicians, of the medical and psychological complexities of "topical steroid ...

The National Eczema Association details seven different kinds of eczema on its website, noting that atopic dermatitis is most common, affecting about half of eczema sufferers.

Sanofi ($SNYNF) announced an update on their ongoing clinical study. Sanofi’s recent clinical study, officially titled ‘A Phase 3, Randomized, ...

These steroids come in various strengths, with lower-potency options available over the counter and higher-potency creams as a prescription. But they're not meant to be a long-term solution for the ...

"In some cases, you could have more intense symptoms when you're transitioning to a new medication, but there are also situations where a drug you've used for a while isn't managing your condition as ...

Incyte (Nasdaq:INCY) today announced new data from the Phase 3b TRuE-AD4 study evaluating the efficacy and safety of Opzelura ® (ruxolitinib cream) in adults with moderate atopic dermatitis (AD) who ...